SCHEMBL8048720

SCHEMBL8048720

CCCCN(C(C)=O)c1ccc(C(N)=O)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.43
MEN1 O00255 1/20 0.43
APAF1 O14727 1/20 0.43
RGS12 O14924 1/20 0.43
HSP90AA1 P07900 1/20 0.43
KMT2A Q03164 1/20 0.43
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
EGFR P00533 1/20 0.42
ERBB2 P04626 1/20 0.42
ALDH1A1 P00352 3/20 0.41
HDAC6 Q9UBN7 2/20 0.41
ADRB2 P07550 1/20 0.41
HDAC1 Q13547 1/20 0.41
MAPT P10636 1/20 0.41
PARP10 Q53GL7 1/20 0.41
MLYCD O95822 1/20 0.41
JAK2 O60674 1/20 0.40
PAX8 Q06710 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8425367 0.90 PARP10 (0.43) MAPK1MEN1APAF1RGS12HSP90AA1
SCHEMBL11887705 0.85 ALOX5 (0.49) NPC1RAB9ASMN1; SMN2ALDH1A1HDAC6
SCHEMBL7279376 0.83 CYP3A4 (0.47) MAPK1NPC1RAB9AEGFRERBB2
SCHEMBL9614627 0.81 HSD17B3 (0.44) MAPK1NPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL817611 0.80 NPC1 (0.59) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL17670515 0.79 NPC1 (0.38) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL13791624 0.79 NPC1 (0.48) MAPK1NPC1RAB9AALDH1A1MAPT
SCHEMBL3930753 0.77 NPC1 (0.50) MAPK1NPC1RAB9AALDH1A1MAPT
SCHEMBL13791114 0.77 RAB9A (0.53) MEN1KMT2ANPC1RAB9AALDH1A1
SCHEMBL13791513 0.75 NPC1 (0.55) NPC1RAB9AALDH1A1MLYCDJAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6077870-A ACETAMIDOBENZAMIDE COMPOUNDS EXHIBIT STRONG ACTIVITY AGAINST PARKINSON'S DISEASE CENTAUR PHARMACEUTICALS, INC. (US) 2000-06-20 US disclosed